Announce Date | 05/28/2025 |
EPS Normalized Actual | $3.67 (Beat by $0.28) |
EPS GAAP Actual | $3.67 (Beat by $0.28) |
Revenue Actual | $1.60427B |
Revenue Surprise | Beat by $1604.27M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2029 | 0 | INF | 0 | 0 | 2 |
Oct 2028 | 0 | INF | 0 | 0 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 2.23 | 2.23 | 1.60427B | 9.32% | 1604.27M |
FQ1 2025 (Jan 2025) | 1.91 | 1.91 | 1.45531B | -13.32% | 1455.31M |
FQ4 2024 (Oct 2024) | 7.12 | 7.12 | 1.63599B | 2.25% | 1635.99M |
FQ3 2024 (Jul 2024) | 2.76 | 2.76 | 1.52575B | 2.52% | 1525.75M |
FQ2 2024 (Apr 2024) | 1.91 | 1.91 | 1.45471B | 100% | 1454.71M |
FQ1 2024 (Jan 2024) | 2.87 | 2.87 | 1.64923B | 17.46% | 1649.23M |
FQ4 2023 (Oct 2023) | 2.28 | 2.28 | 1.59913B | 19.69% | 1599.13M |
FQ3 2023 (Jul 2023) | 2.21 | 2.21 | 1.48729B | 16.1% | 1487.29M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Oct 2028) | 6.66 | -- | 6.64468 | 6.66621 | 6 |
FQ3 2028 (Jul 2028) | 6.1 | -- | 6.08597 | 6.10569 | 6 |
FQ2 2028 (Apr 2028) | 5.93 | -- | 5.91636 | 5.93553 | 6 |
FQ1 2028 (Jan 2028) | 6.33 | -- | 6.31544 | 6.33591 | 6 |
FQ4 2027 (Oct 2027) | 5.5948 | -- | 5.54636 | 5.62593 | 9 |
FQ3 2027 (Jul 2027) | 5.0666 | -- | 5.02273 | 5.09479 | 6 |
FQ2 2027 (Apr 2027) | 4.4118 | -- | 4.3736 | 4.43635 | 11 |
FQ1 2027 (Jan 2027) | 4.37435 | -- | 4.36429 | 4.37843 | 9 |
FQ4 2026 (Oct 2026) | 5.27083 | -- | 5.21317 | 5.35999 | 2 |
FQ3 2026 (Jul 2026) | 4.99935 | -- | 4.94466 | 5.08391 | 2 |
FQ2 2026 (May 2026) | 4.095 | 45.54 | 3.93449 | 4.21557 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Oct 2028) | 2.6B | -- | 2.59B | 2.6B | 5 |
FQ3 2028 (Jul 2028) | 2.46B | -- | 2.46B | 2.46B | 5 |
FQ2 2028 (Apr 2028) | 2.37B | -- | 2.37B | 2.37B | 5 |
FQ1 2028 (Jan 2028) | 2.48B | -- | 2.47B | 2.48B | 5 |
FQ4 2027 (Oct 2027) | 2.07B | -- | 2.06B | 2.08B | 10 |
FQ3 2027 (Jul 2027) | 2.01B | -- | 1.99B | 2.01B | 7 |
FQ2 2027 (Apr 2027) | 1.94B | -- | 1.93B | 1.95B | 12 |
FQ1 2027 (Jan 2027) | 2.03B | -- | 2.03B | 2.03B | 10 |
FQ4 2026 (Oct 2026) | 6.18B | -- | 6.13B | 6.27B | 6 |
FQ3 2026 (Jul 2026) | 5.77B | -- | 5.72B | 5.85B | 3 |
FQ2 2026 (May 2026) | 1.86B | 13.73 | 1.8B | 1.9B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 2.23 | 2.23 | 100% | |
FQ1 2025 (Jan 2025) | 1.91 | 1.91 | 100% | |
FQ4 2024 (Oct 2024) | 7.12 | 7.12 | 100% | |
FQ3 2024 (Jul 2024) | 2.76 | 2.76 | 100% | |
FQ2 2024 (Apr 2024) | 1.91 | 1.91 | 100% | |
FQ1 2024 (Jan 2024) | 2.87 | 2.87 | 100% | |
FQ4 2023 (Oct 2023) | 2.28 | 2.28 | 100% | |
FQ3 2023 (Jul 2023) | 2.21 | 2.21 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $1.6B | $1604.27M | 100% |
FQ1 2025 (Jan 2025) | $0B | $1.46B | $1455.31M | 100% |
FQ4 2024 (Oct 2024) | $0B | $1.64B | $1635.99M | 100% |
FQ3 2024 (Jul 2024) | $0B | $1.53B | $1525.75M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.45B | $1454.71M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.65B | $1649.23M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.6B | $1599.13M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.49B | $1487.29M | 100% |